DiABZI-i
DiABZI-i is a orthosteric STING inhibitor. diABZI-i significantly inhibits cGAMP-induced IFNβ in PBMCs with an IC50 of 49 nM. diABZI-i also activates V155M SAVI constitutive signaling in STING V155M THP-1 cells model with potent agonism (EC50: 17 nM) . diABZI-i can be used for monogenic autoinflammatory disease like SAVI disease research[1].
Product Specifications
UNSPSC
12352005
Target
STING
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology
Smiles
CCN1N=CC=C1C(/N=C2N(C3=C(N\2C/C(C)=C(CN4C5=C(C=C(C=C5N(/C4=N\C(C6=CC(C)=NN6CC)=O)C)C(N)=O)OCC7=CC=CC(OC)=C7)\C)C=CC(C(N)=O)=C3)C)=O
Molecular Formula
C45H50N12O6
Molecular Weight
854.96
References & Citations
[1]Xie T, et al. Orthosteric STING inhibition elucidates molecular correction of SAVI STING. Nat Commun. 2025 Jul 1;16 (1) :5695.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD81 / TAPA-1 (1.3.3.22), CF488A conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF568 conjugate, 0.1mg/mL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF568 conjugate, 0.1mg/mL
